ArticleEuropean journal of public health2026
Age at menarche association with metabolic, reproductive, and sociodemographic factors: a population-based cross-sectional analysis using an outcome-wide framework in Geneva, Switzerland.
Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A global decline in age at menarche has raised concerns about its long-term health and social consequences. This study investigates temporal trends in age at menarche in a Swiss population born between 1936 and 1989 and assesses associations with sociodemographic, metabolic, and reproductive health factors. Age at menarche was examined across birth cohorts to assess temporal trends. Using an outcome-wide analytical framework, adjusted for age, survey year, and education, logistic and linear regression models examined the associations between menarche timing and sociodemographic, metabolic, and reproductive health factors. The sample included 6462 women aged 34-75. Mean age at menarche was 13.1 years, decreasing from 14.1 (born in 1936) to 12.9 (born in 1989). Early menarche (<12 years) was associated with lower income (aOR = 0.79; 95% CI: 0.67-0.93), higher odds of hypertension (aOR 1.41; 1.18-1.67), diabetes (aOR 1.40; 1.05-1.83), hypercholesterolemia (aOR 1.27; 1.07-1.49), shorter stature (-2.12 cm), higher BMI, increased hysterectomy prevalence (aOR 1.69; 1.33-2.13), and longer reproductive lifespan (+1.59 years). Late menarche (>14 years) was associated with increased stillbirth (aOR 1.80; 1.12-2.84) and ectopic pregnancy risks (aOR 1.45; 1.04-2.00) (however to be seen as exploratory as not significant after FDR correction), different menstrual patterns, reduced reproductive lifespan (-3.12 years), and lower education (aOR 0.81; 0.71-0.93). Age at menarche has declined in Geneva and is associated with various health outcomes. Including menarche timing in clinical assessments could improve risk stratification and preventive care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.